PeopleBio Inc (304840) fair value: what the stock is really worth
As of Nov 20, 2026: fair value (intrinsic value) of PeopleBio Inc stock ₩1,423, price ₩1,586, that is 10.3% below the price, quality 19 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently applies, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
PeopleBio Inc
304840 · KQExpensive (fair value 10% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 22, 2026.
How to read this chart
60‑month range ₩1,122 – ₩39,773 · fair‑value band ₩1,067 – ₩1,779 · the ₩1,586 price screens above the ₩1,423 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 22, 2026.
Every Wednesday you see whether PeopleBio is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
PeopleBio, Inc., a biotech company, engages in developing diagnostics for protein misfolding diseases worldwide.
Show moreShow less
Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases.
The company has strategic collaborations with Seoul National University Bundang Hospital, Etablissement Français du Sang, ADNI Private Partner Scientific Board, Eisai Co., Ltd., Macrogen Corp., ZheJiang Dian Diagnostics Co., Ltd., and LabGenomics, Inc. PeopleBio, Inc. was founded in 2002 and is based in Seongnam, South Korea.
Stock analysis
PeopleBio Inc (304840) currently trades at ₩1,586, while our estimate is ₩1,423, 10% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently applies to this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: ₩1,067 (bear) to ₩1,779 (bull), the price of ₩1,586 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 19/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
PeopleBio Inc reported revenue of 2.9B KRW in FY2025 versus 577M KRW in FY2021, a compound +49.1%/yr. Reported net income was −15.7B KRW in FY2025.
Key figures
Market cap 39.4B KRW (≈ $29.5M) Micro · P/S ratio 5.38 · Net margin −94.7% · Return on equity −10,161% · Return on assets (EBIT) −32.4% (5-year average) · Operating margin −227% · Revenue (TTM) 3.7B KRW · Revenue growth (quarter YoY) +422%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 5 out of 100 (medium confidence).
What moves the price
The share trades about 57% below its 52-week high and 41% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at −10%, 304840 screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
304840 screens overvalued: fair value 10% below the price. Compare with InBody Co →
Compare PeopleBio Inc with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Healthcare Equipment & Supplies” was too small, so the broader sector is used.)Health Care · 2787 stocks
Valuation Multiplesvs Health Care median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- EBIT margin by industry
- P/S ratio by industry
- PEG screener for stocks with fair value
- Undervalued stocks: South Korean Stocks
- Valuation of the Korea market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Healthcare Equipment & Supplies stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Value Added Technology Co 043150 | ₩16,710 | ₩48,636 | +191% | vs 304840 |
| Sewoon Medical Co 100700 | ₩2,180 | ₩5,541 | +154% | vs 304840 |
| Meta Biomed Co 059210 | ₩3,405 | ₩6,997 | +105% | vs 304840 |
| InBody Co 041830 | ₩42,450 | ₩49,984 | +18% | vs 304840 |
| MEKICS CO., Ltd 058110 | ₩1,312 | ₩1,452 | +11% | vs 304840 |
| AbbVie Inc ABBV | $286.20 | $259.62 | −9% | vs 304840 |
| Roche Holding RO | CHF 402.60 | CHF 326.56 | −19% | vs 304840 |
| Mediana Co 041920 | ₩7,010 | ₩5,424 | −23% | vs 304840 |
| Johnson & Johnson, JNJ | $270.47 | $169.03 | −38% | vs 304840 |
| Eli Lilly and Company LLY | $1,347.11 | $749.92 | −44% | vs 304840 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is PeopleBio Inc (304840) overvalued or undervalued?
What is the fair value of 304840?
What is the quality score of 304840?
What is the price target for PeopleBio Inc (304840)?
What is the PeopleBio Inc stock forecast for 2026?
What is the revenue of PeopleBio Inc (304840)?
What is the intrinsic value of PeopleBio Inc (304840)?
Is PeopleBio Inc stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 304840?
How much is PeopleBio Inc worth?
What do the bullish and bearish scenarios say about 304840?
How far is 304840 from its 52-week high?
Which stocks are comparable to PeopleBio Inc?
Is PeopleBio Inc stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of PeopleBio Inc (304840)?
What should I pay attention to with PeopleBio Inc right now?
Key figures of PeopleBio Inc
How large is the market capitalisation of PeopleBio Inc (304840)?
What is the P/S ratio of PeopleBio Inc (304840)?
What is the net margin of PeopleBio Inc (304840)?
What is the return on equity of PeopleBio Inc (304840)?
What is the EBIT return on assets of PeopleBio Inc (304840)?
What is the operating margin of PeopleBio Inc (304840)?
How fast is revenue growing at PeopleBio Inc (304840)?
How much free cash flow does PeopleBio Inc (304840) generate?
How much net debt does PeopleBio Inc (304840) carry?
Watch PeopleBio Inc in the live analysis
One click puts PeopleBio Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.